COVID-19 Vaccines For 2022

Authored by
Staff
Last reviewed
June 29, 2022

COVID-19 Vaccines For 2022

Globally, innovative platforms such as DNA, mRNA, virus-like particles, viral vector, recombinant protein, live attenuated and inactivated virus approaches have developed COVID-19 vaccines.

On August 23, 2021, the U.S. Food and Drug Administration (FDA) Authorized the Pfizer-BioNTech mRNA Comirnaty vaccine and Approved the SpikeVax from Moderna, Inc. in 2022. And the Jcovden - Janssen COVID-19 vaccine is Authorized for use in the USA as of June 2022.

The European Medicines Agency has Authorized (5) COVID-19 vaccines.

Furthermore, the WHO has Listed eleven COVID-19 vaccines. And GAVI recently reported over (120) COVID-19 vaccine candidates underwent clinical trials.

Additional vaccine news is published at PrecisionVaccinations.com/vaccines.